關於Belkyra®溶脂療程
About Belkyra®
Belkyra® 能高效定點針對脂肪雙下巴。
科研實證，有效永久消滅雙下巴脂肪，
讓你擺脫雙下巴所帶來的煩惱。3-6
作為世界級首創的溶脂配方，Belkyra®內含專利成分
去氧膽酸deoxycholic acid (DCA)，
透過直接作用於治療位置的脂肪層，
破壞脂肪細胞的細胞膜，
導致不可逆轉的脂肪細胞分解。6
Belkyra® is the first-in-class treatment, clinically proven to destroy fat cells under chin to improve submental contour.3-6
With the patent formulation of deoxycholic acid (DCA), which is bioequivalent to the naturally occurring molecule, Belkyra® specifically target to destroy undesired fat, resulting in a noticeable reduction in fullness under the chin.6
Belkyra®溶脂療程擁有科研實證
效果顯著 安全可靠3-6Clinically proven to be effective and safe3-6
定點永久摧毀脂肪細胞6
Permanently destroy fat cells6
非手術性療程
Non-surgical procedure
美國FDA及歐洲EMA認可10†,11
US FDA and EMA approved10†,11
5年長期安全數據支持12
Long-term safety study datafor up to 5 years12
平均2-4次療程9
Average 2 - 4 treatment sessions9
每次約需30分鐘
Each taking about 30 minutes
Retreatment is not expected after
final aesthetic results are achieved4,6
*Minimal invasive treatment in adipolysis †Approved as Kybella™ in US10
^資料來源：根據美國食物及藥物監督管理局 (U.S. Food and Drug Administration) 官方網站, 去氧膽酸(Belkyra®主要成份) 是唯一認可用作改善雙下巴脂肪8 https://www.fda.gov/search?s=deoxycholic+acid (截至2022年8月9日).
References: 1. Goodman GJ, et al. Dermatol Surg 2016;42(suppl 1):S260-262. 2. DeFatta R, Ducic Y. Oper Tech Otolaryngol 2007;18(3):261-266. 3. Ascher B, et al. J Eur Acad Dermatol Venereol 2014 Dec;28(12):1707-15. 4. Humphrey S, et al. J Am Acad Dermatol 2016;75(4):788-797; 5. Jones DH, et al. Dermatol Surg 2016;42(1):38-49; 6. Rzany B, et al. Br J Dermatol. 2014;170(2):445-453; 7. Schlessinger J, et al. Skinmed. 2013;11:27–31; 8. Dayan SH, et al. Dermatol Surg 2016;42(suppl 1):S263–S270; 9. Belkyra® Prescribing Information. March 2021; 10. U.S. Food and Drug Administration, Department of Health & Human Services. Kyrbella™ deoxycholic acid injection, 10mg/ml approval letter NDA 206333, Apr 2015; 11. European Medicines Agency. List of nationally authorized medicinal products. EMA/753957/2017. November 2017; 12. Bhatia AC, et al. Poster presented at The Maui Derm for Dermatologists Conference. 20-24 March 2017; 13. Teller CF et al. Plast Reconstr Surg Glob Open. 2021 Jul 12;9(7):e3668; 14. Photo courtesy: Dr Vincent Yang.
Belkyra® (deoxycholic acid) 藥品註冊編號: HK-65660。Belkyra®為醫生處方藥物，請向醫生或醫學美容中心諮詢切合您獨特需要的專屬療程方案。療程效果因人而異。療程後如有任何不良反應，請即向醫生查詢。All adverse events should be reported to drugsafety.pv@abbvie.com.
香港北角電氣道 183 號友邦廣場 24 樓 2404-08 室電話: (852)26102525
© 2022 Allergan Aesthetics. All right reserved. Approval Date: 01/SEP/22 | HK-BEL-220020
